Avadel Pharmaceuticals PLC AVDL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:56 PM EDT
16.90quote price arrow up+0.38 (+2.30%)
Volume
136,545
Close
16.52quote price arrow up+0.69 (+4.36%)
Volume
1,752,360
52 week range
9.50 - 19.09
Loading...
  • Open15.77
  • Day High17.14
  • Day Low15.70
  • Prev Close15.83
  • 52 Week High19.09
  • 52 Week High Date05/03/24
  • 52 Week Low9.50
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap1.588B
  • Shares Out96.12M
  • 10 Day Average Volume1.34M
  • Dividend-
  • Dividend Yield-
  • Beta1.76
  • YTD % Change17

KEY STATS

  • Open15.77
  • Day High17.14
  • Day Low15.70
  • Prev Close15.83
  • 52 Week High19.09
  • 52 Week High Date05/03/24
  • 52 Week Low9.50
  • 52 Week Low Date10/27/23
  • Market Cap1.588B
  • Shares Out96.12M
  • 10 Day Average Volume1.34M
  • Dividend-
  • Dividend Yield-
  • Beta1.76
  • YTD % Change17

RATIOS/PROFITABILITY

  • EPS (TTM)-1.86
  • P/E (TTM)-8.88
  • Fwd P/E (NTM)-43.13
  • EBITDA (TTM)-133.867M
  • ROE (TTM)-780.02%
  • Revenue (TTM)55.141M
  • Gross Margin (TTM)95.71%
  • Net Margin (TTM)-284.42%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Avadel Pharmaceuticals PLC

 

Profile

MORE
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's lead product, LUMRYZ, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME and...
Geoffrey Glass
Non-Executive Independent Chairman of the Board
Gregory Divis Jr.
Chief Executive Officer, Director
Thomas McHugh
Chief Financial Officer
Address
Block 10-1 Blanchardstown Corporate Park
Ballycoolin
Dublin
15
Ireland

Top Peers

SYMBOLLASTCHG%CHG
EYPT
EyePoint Pharmaceuticals Inc
12.09-0.58-4.58%
OCUL
Ocular Therapeutix Inc
5.66-0.18-3.08%
SIGA
SIGA Technologies Inc
7.46-0.29-3.74%
IRWD
Ironwood Pharmaceuticals Inc
7.00+0.26+3.86%
ANIP
ANI Pharmaceuticals Inc
68.05+2.17+3.29%